bevacizumab
网络释义：贝伐单抗；贝伐珠单抗；贝伐株单抗
网络释义
1.贝伐单抗贝伐单抗(bevacizumab)是一种重组人源化抗VEGF单克隆抗体,在2005年ASCO会议上报道的一项随机Ⅲ期临床试验中,病人接受 …
2.贝伐珠单抗贝伐珠单抗（Bevacizumab）：商品名Avastin，年销售额62.6亿美元聚乙二醇干扰素（Pegylated interferon alfa-2a）：商品名…
3.贝伐株单抗其中一种名为贝伐株单抗（Bevacizumab）的标靶药物，进行维期半年疗程，费用需约十万元。该药物未列入撒玛利亚基金资 …
4.阿瓦斯汀阿瓦斯汀(Bevacizumab)是重组的人源化单克隆抗体。通过体内、体外检测系统证实IgG1抗体能与人血管内皮生长因子(VEGF) …
5.安维汀他们审核了罗氏的安维汀（bevacizumab）2006~2009年间在英国、德国、法国和意大利的使用数据。安维汀获准用来治疗晚 …
6.阿瓦斯丁阿瓦斯丁（bevacizumab）对大鼠角膜新生血管视网膜干细胞的分离、分化陈穗桦 蒋峰 夏斯龙* 杨丽萍 尹捷 姜涛 南京军区南 …
例句释义:,贝伐单抗,贝伐珠单抗,贝伐株单抗1."Our hope now, " he added, "is to see greater improvement by using bevacizumab at earper stages of the disease. "他补充说：“我们的希望是看到在疾病早期用贝伐单抗就能显著改善患者病情。”
2.In the phase II study, the rate of pfe-threatening and fatal pulmonary hemorrhages had been increased with bevacizumab treatment (9. 1%).在II期研究中，贝伐单抗治疗导致的致命率和致死性肺出血就已经增加（9.1%）。
3.Patients taking higher dosages of bevacizumab had the greatest risk of developing proteinuria.接受更高剂量的贝伐单抗的患者有更大的患蛋白尿的风险。
4.Bevacizumab treatment was associated with a low rate of serious adverse events.贝伐单抗治疗严重不良事件率很低。
5.Bevacizumab, a recombinant humanized anti-VEGF monoclonal antibody, has proven beneficial to cancer therapy.贝伐单抗为重组人源化抗VEGF的单克隆抗体，其治疗肿瘤具有良好的效果。
6.ObjectiveTo evaluate the efficacy and safety of bevacizumab plus capecitabine in treating metastatic colorectal cancer(mCRC).目的观察贝伐单抗联合卡培他滨治疗转移性结直肠癌的疗效及不良反应。
7.The use of bevacizumab (as well as cetuximab) for maintenance remains unproven, however.贝伐单抗（以及西妥昔单抗）对维持治疗仍无提高。
8.This trial provides level-one evidence for the use of bevacizumab injections for the treatment of wet AMD, they conclude.他们得出结论，这项试验提供了贝伐单抗注射用于治疗湿性老年黄斑变性AMD一级证据。
9.Avastin, the trade name of bevacizumab, is marketed by Swiss pharmaceutical giant Roche.阿瓦斯丁是贝伐单抗的商品名，这种药由瑞士罗氏制药企业在市场上出售。
10.At one point Avastin, also called bevacizumab, seemed a shoo-in to be approved for breast cancer.从治疗效果来讲，阿瓦斯汀，又被称为贝伐单抗，似乎呼声很高地被批准成为乳腺癌治疗用药。